HERON THERAPEUTICS, INC. /DE/ Increase (Decrease) in Inventories
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Increase (Decrease) in Inventories of $852.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-10
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in inventories for the quarter ending 2026-06-30 was $683.00K, a 95.74% decline year-over-year.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in inventories for the quarter ending 2026-03-31 was $169.00K, a 95.52% decline year-over-year.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in inventories for the quarter ending 2025-12-31 was $14.19M, a 96.77% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in inventories for the quarter ending 2025-09-30 was -$2.94M, a 195.27% decline year-over-year.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in inventories for fiscal 2025 was $31.05M, a 181.01% increase from fiscal 2024.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in inventories for fiscal 2024 was $11.05M.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in inventories for fiscal 2023 was -$12.46M, a 301.31% decline from fiscal 2022.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in inventories for fiscal 2022 was $6.19M, a 4.42% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | $683.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $852.00K 10-Q · filed 2026-08-10 | $15.04M derived: sum of 3 quarters · filed 2026-08-10 | $12.10M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $169.00K 10-Q · filed 2026-05-11 | $14.36M derived: sum of 2 quarters · filed 2026-05-11 | $11.42M derived: sum of 3 quarters · filed 2026-05-11 | $27.45M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $14.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $11.25M derived: sum of 2 quarters · filed 2026-02-26 | $27.28M derived: sum of 3 quarters · filed 2026-08-10 | $31.05M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$2.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $13.09M derived: sum of 2 quarters · filed 2026-08-10 | $16.86M 10-Q · filed 2025-11-04 | $24.07M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $16.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $19.80M 10-Q · filed 2026-08-10 | $27.02M derived: sum of 3 quarters · filed 2026-08-10 | $30.10M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $3.77M 10-Q · filed 2026-05-11 | $10.98M derived: sum of 2 quarters · filed 2026-05-11 | $14.07M derived: sum of 3 quarters · filed 2026-05-11 | $14.46M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $7.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $10.30M derived: sum of 2 quarters · filed 2026-02-26 | $10.69M derived: sum of 3 quarters · filed 2026-02-26 | $11.05M 10-K · filed 2026-02-26 |
| 2024-09-30 | $3.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $3.48M derived: sum of 2 quarters · filed 2025-11-04 | $3.84M 10-Q · filed 2025-11-04 | $3.94M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $391.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $754.00K 10-Q · filed 2025-08-08 | $857.00K derived: sum of 3 quarters · filed 2026-02-26 | -$1.76M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $363.00K 10-Q · filed 2025-05-06 | $466.00K derived: sum of 2 quarters · filed 2026-02-26 | -$2.15M derived: sum of 3 quarters · filed 2026-02-26 | -$9.59M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$2.51M derived: sum of 2 quarters · filed 2026-02-26 | -$9.95M derived: sum of 3 quarters · filed 2026-02-26 | -$12.46M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$2.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$10.05M derived: sum of 2 quarters · filed 2024-11-12 | -$12.57M 10-Q · filed 2024-11-12 | -$10.23M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$7.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$9.95M 10-Q · filed 2024-08-06 | -$7.62M derived: sum of 3 quarters · filed 2025-02-27 | -$16.70M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$2.51M 10-Q · filed 2024-05-07 | -$180.00K derived: sum of 2 quarters · filed 2025-02-27 | -$9.26M derived: sum of 3 quarters · filed 2025-02-27 | -$4.41M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$6.75M derived: sum of 2 quarters · filed 2025-02-27 | -$1.90M derived: sum of 3 quarters · filed 2025-02-27 | $6.19M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$9.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$4.23M derived: sum of 2 quarters · filed 2023-11-14 | $3.86M 10-Q · filed 2023-11-14 | $10.74M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $4.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $12.94M 10-Q · filed 2023-08-14 | $19.82M derived: sum of 3 quarters · filed 2023-08-14 | $18.52M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $8.09M 10-Q · filed 2023-05-11 | $14.97M derived: sum of 2 quarters · filed 2023-05-11 | $13.67M derived: sum of 3 quarters · filed 2023-05-11 | $13.84M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $6.88M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $5.58M derived: sum of 2 quarters · filed 2023-03-29 | $5.75M derived: sum of 3 quarters · filed 2023-03-29 | $6.48M 10-K · filed 2023-03-29 |
| 2021-09-30 | -$1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$1.13M derived: sum of 2 quarters · filed 2022-11-08 | -$403.00K 10-Q · filed 2022-11-08 | -$1.25M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $171.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $895.00K 10-Q · filed 2022-08-09 | $51.00K derived: sum of 3 quarters · filed 2022-08-09 | $1.36M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $724.00K 10-Q · filed 2022-05-09 | -$120.00K derived: sum of 2 quarters · filed 2022-05-09 | $1.19M derived: sum of 3 quarters · filed 2022-05-09 | $7.78M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | -$844.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $463.00K derived: sum of 2 quarters · filed 2022-02-28 | $7.06M derived: sum of 3 quarters · filed 2022-02-28 | $16.94M 10-K · filed 2022-02-28 |
| 2020-09-30 | $1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $7.90M derived: sum of 2 quarters · filed 2021-11-03 | $17.78M 10-Q · filed 2021-11-03 | $18.58M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $6.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $16.47M 10-Q · filed 2021-08-09 | $17.27M derived: sum of 3 quarters · filed 2022-02-28 | $12.17M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $9.88M 10-Q · filed 2021-05-10 | $10.68M derived: sum of 2 quarters · filed 2022-02-28 | $5.58M derived: sum of 3 quarters · filed 2022-02-28 | $3.43M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $796.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$4.30M derived: sum of 2 quarters · filed 2022-02-28 | -$6.45M derived: sum of 3 quarters · filed 2022-02-28 | -$14.06M 10-K · filed 2022-02-28 |
| 2019-09-30 | -$5.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$7.25M derived: sum of 2 quarters · filed 2020-11-05 | -$14.86M 10-Q · filed 2020-11-05 | -$7.24M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | -$2.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$9.76M 10-Q · filed 2020-08-05 | -$2.14M derived: sum of 3 quarters · filed 2021-02-24 | $2.07M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | -$7.61M 10-Q · filed 2020-05-06 | $9.00K derived: sum of 2 quarters · filed 2021-02-24 | $4.22M derived: sum of 3 quarters · filed 2021-02-24 | $12.00M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $7.62M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $11.84M derived: sum of 2 quarters · filed 2021-02-24 | $19.61M derived: sum of 3 quarters · filed 2021-02-24 | $29.12M 10-K · filed 2021-02-24 |
| 2018-09-30 | $4.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $11.99M derived: sum of 2 quarters · filed 2019-11-12 | $21.50M 10-Q · filed 2019-11-12 | $26.44M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $7.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $17.29M 10-Q · filed 2019-08-05 | $22.23M derived: sum of 3 quarters · filed 2020-03-02 | $22.59M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $9.51M 10-Q · filed 2019-05-09 | $14.45M derived: sum of 2 quarters · filed 2020-03-02 | $14.81M derived: sum of 3 quarters · filed 2020-03-02 | $14.97M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $4.94M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $5.31M derived: sum of 2 quarters · filed 2020-03-02 | $5.47M derived: sum of 3 quarters · filed 2020-03-02 | $4.77M 10-K · filed 2020-03-02 |
| 2017-09-30 | $368.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $528.00K derived: sum of 2 quarters · filed 2018-11-07 | -$171.00K 10-Q · filed 2018-11-07 | $3.19M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-06-30 | $160.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$539.00K 10-Q · filed 2018-08-08 | $2.82M derived: sum of 3 quarters · filed 2019-02-22 | $1.49M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-03-31 | -$699.00K 10-Q · filed 2018-05-10 | $2.66M derived: sum of 2 quarters · filed 2019-02-22 | $1.33M derived: sum of 3 quarters · filed 2019-02-22 | $1.90M derived: sum of 4 quarters · filed 2019-02-22 |
| 2016-12-31 | $3.36M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $2.03M derived: sum of 2 quarters · filed 2019-02-22 | $2.60M derived: sum of 3 quarters · filed 2019-02-22 | $5.34M 10-K · filed 2019-02-22 |
| 2016-09-30 | -$1.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$761.00K derived: sum of 2 quarters · filed 2017-11-06 | $1.98M 10-Q · filed 2017-11-06 | |
| 2016-06-30 | $568.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $3.31M 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | $2.74M 10-Q · filed 2017-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |